Establishment Labs Holdings Inc. announced the appointment of Peter Caldini as Chief Executive Officer, effective May 7, 2025. Mr. Caldini had been serving as Interim CEO since March 1, 2025, following the retirement of founder Juan José Chacón-Quirós.
Nick Lewin, Chairman of the Board, stated that Mr. Caldini's deep operational, commercial, and financial skills make him the ideal leader to ensure the company accomplishes its goals. These goals include achieving positive EBITDA in 2025 and becoming cash flow positive in 2026.
Mr. Caldini expressed his honor in leading Establishment Labs, emphasizing the company's unique position to transform breast aesthetics and reconstruction globally through innovation. He plans to marry innovation and best-in-class products with operational excellence to deliver value to all stakeholders.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.